References
- 1. Agbogu, V. N., Umoh, V. J., Charles, A. O., Smith, S. I, Joseph, B. A., 2006: Study of the bacteriological and physiological indicators of pollution of surface waters in Zaria, Nigeria. AJB, 5, 9, 732—737.
- 2. Akobi, B., Aboderin, O., Sasaki, T., Shittu, A., 2012: Characterization of Staphylococcus Aureus isolates from faecal samples of the straw-coloured Fruit Bat (Eidolon Helvum) in Obafemi Awolowo University (OAU), Nigeria. BMC Microbiol., 12, 1, 279. DOI: 10.1186/1471-2180-12-279.10.1186/1471-2180-12-279355457923181939
- 3. Aliyu, A. A., Ajogi, I. A., Ajanusi, O. J., Reuben, R. C., 2014: Epidemiological studies of Fasciola gigantica in cattle in Zaria, Nigeria, using coprology and serology. J. Public Health Epidemiol., 6, 2, 85—91. DOI: 10.58971/JPHE2013.0535.
- 4. Ananthakrishnan, A., 2011:Clostridium difficile infection; risk factors and management. Nature Review Gastroenterol. Hepatol., 8, 1, 17—26. DOI: 10.1038/nrgastro.2010.190.10.1038/nrgastro.2010.19021119612
- 5. Barrow, G. I., Feltham, R. K. A., 2003:Cowan and Steel’s Manual for the Identification of Medical Bacteria. 3rd edn., Cambridge University Press, UK, 94—163.
- 6. Bauer, A. W., Kirby, W. M., Sherris, J. C., Turck, M., 1966: Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol., 45, 4, 493—496.10.1093/ajcp/45.4_ts.493
- 7. Beshiru, A., Igbinasa, I. H., Igbinosa, E. O., 2016: An investigation on antibiogram characteristic of Escherichia coli isolated from piggery farms in Benin City, Nigeria. AST, 1, 1, 8—12. DOI: 10.22366/ast.2016.01.002.10.22366/ast.2016.01.002
- 8. Brook, I., Wexler, H. M, Goldstein, E. J. C., 2013: Anti-anaerobic and antimicrobials: spectrum and susceptibility testing. Clin. Microbiol. Rev., 26, 3, 526—546. DOI: 10.1128/CMR.00086-12.10.1128/CMR.00086-12371949623824372
- 9. Carter, G. P., Rood, J. I., Lyras, D., 2010: The role of toxin A and toxin B in Clostridium difficile associated disease, past and present perspectives. Gut Microbes, 1, 1, 58—64. DOI: 4161/gmic.1.1.10768.10.4161/gmic.1.1.10768290682220664812
- 10. Chan, G., Farzan, A., Prescott, J. F., Friendship, R., 2013: How do swine practitioners and veterinary pathologist arrive at diagnoses of Clostridium perfringens type A enteritis in neonatal piglets. Can. Vet. J., 54, 5, 504—506.
- 11. Chan, G., Farzan, A., Soltes, G., Nicholson, V. M, Pei, Y., Friendship, R., et al., 2012: The epidemiology of Clostridium perfringens type A on Ontario swine farms, with special reference to cpb2 positive isolates. BMC Vet. Res., 8, 156. DOI: 10. 1186/1746-6148-8-156.10.1186/1746-6148-8-156350384522947389
- 12. Chukwu, E. E., Nwaokorie, F. O., Coker, A. O., Avila-Campos, M. J., Ogunsola, F. T., 2017: Genetic variation among Clostridium perfringens isolated from food and faecal specimens in Lagos. Microb. Pathog., 111, 232—237. DOI: 10. 1016/j.micpath.2017.08.031.10.1016/j.micpath.2017.08.03128867621
- 13. Clinical and Laboratory Standard Institute, 2018:Performance Testing for Antimicrobial Susceptibility Testing. 28th edn., CLSI supplement M100. Clinical and Laboratory Standard Institute, Wayne, PA, 96—100.
- 14. Cromwell, G. L., 2002: Why and how antibiotics are used in swine production. Anim. Biotechnol., 13, 1, 7—27. DOI: 10. 1081/ABIO-120005767.10.1081/ABIO-12000576712212945
- 15. Davies, A. H., Roberts, A. K., Shone, C. C., Acharya, K. R., 2011: Super toxins from a superbug: structure and function of Clostridium difficile toxins. Biochem. J., 436, 517—526. DOI: 10. 1042/BJ20110106.10.1042/BJ2011010621615333
- 16. European Committee on Antimicrobial Susceptibility, 2018:Testing. Breakpoints Tables for Interpretation of MICs and Zone Diameters, Version 8.0. 2018. http://WWW.eucast.org. Accessed in May, 2018.
- 17. Eyre, J. W. H., 2009: The Project Gutenberg Book of the Elements of Bacteriological Technique. A Laboratory Guide for Medical, Dental and Technical Students. 2nd edn., Rewritten and enlarged. W. B. Saunders Company Press, Philadelphia, 276—305.
- 18. Fashae, K., Hendriksen, R. S., 2014: Diversity and antimicrobial susceptibility of Salmonella enterica serovars isolated from pig farms in Ibadan, Nigeria. Folia Microbiol., 59, 1, 69—77. DOI: 10.1007/s12223-013-0270-6.10.1007/s12223-013-0270-623893398
- 19. Ferreira, T. S. P., Moreno, M. A., de Almeida, R. R., Gomes, C. R., Sena de Gobhi, D. D., Lima Filsner, P. H. N., et al., 2012: Molecular typing of Clostridium perfringens isolated from swine in slaughterhouses from Sao Paolo State, Brazil. Cienc. Rural, 42, 8, 1450—1456.10.1590/S0103-84782012000800020
- 20. Jeffrey, E. R., Stanley, M. H., 2001:Clostridium perfringens in US Food and Drug Administration. Bacteriological Analytical Manual. 8th edn., Chapter 16. https://www.academia.edu/23345561/Bacteriological_Analytical_Manual. Accessed in May, 2018.
- 21. Karczmarczyk, M., Martins, M., Quinn, T., Leonard, N., Fanning, S., 2011: Mechanisms of fluoroquinolone resistance in Escherichia coli isolates from food-producing animals. Appl. Environ. Microbiol., 77, 20, 7113—7120. DOI: 10. 1128/AEM.00600-11.10.1128/AEM.00600-11319484621856834
- 22. Kiu, R., Hall, L. J., 2018: An update on the human and animal enteric pathogen Clostridium perfringens. Emerg. Microbes Infect., 7, 141. DOI: 10. 1038/s41426-018-0144-8.
- 23. Lawson, P. A., Citron, D. M., Tyrrell, K. L., Finegold, S. M., 2016: Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O’Toole, 1935) Prevot 1938. Anaerobe, 40, 95—99. DOI: 10. 1016/j.anaerobe.2016.06.008.10.1016/j.anaerobe.2016.06.00827370902
- 24. Maikai, B. V., Umoh, J. U., Kwaga, J. K. P., Maikai, V. A., Egege, S. C., 2009: Prevalence and risk factors associated with faecal shedding of Cryptosporidium oocyst in piglets, Kaduna, Nigeria. J. Parasitol. Vector Biol., 1, 1, 001—004.
- 25. McClane, B. A., 2007:Clostridium perfringens. In Doyle, M. P., Beuchat, L. R.:Food Microbiology: Fundamentals and Frontiers. 3rd. edn., Washington DC, ASM Press, 423—444.10.1128/9781555815912.ch19
- 26. Modi, N., Gulati, N., Solomon, K., Monaghan, T., Robins, A., Sewell, F. H., et al., 2011: Differential binding and internalization of Clostridium difficile toxin A by human peripheral blood monocytes, neutrophils and lymphocytes. Scand. J. Immunol., 74, 3, 264—271. DOI: 10.1111/j.1365-3083.2011..02578.x.
- 27. Momoh, A. H., Kwaga, J. K. P., Bello, M., Sackey, A. K. B., 2016: Prevalence and antimicrobial resistance pattern of coagulase negative Staphylococci isolated from pigs and in contact with humans in Jos, metropolis. Nig. Vet. J., 37, 3, 140—147.
- 28. Moono, P., 2017:Aspects of Clostridium difficile Infection in Pigs. Thesis, 4.4: Discussion, 82—85. www.researchgate.net/publication/321373143. Accessed in June 17, 2018.
- 29. Nerandzic, M. M., Pultz, M. J., Donskey, C. J., 2009: Examination of potential mechanisms to explain the association between proton pump inhibitors and Clostridium difficile infection. Antimicrob. Agents Chemother., 53, 10, 4133—4137. DOI: 10.1128/AAC.00252-09.10.1128/AAC.00252-09276423019667292
- 30. Ngamwongsatit, B., Tanomsridachchai, W., Suthienkul, O., Urairong, S., Navasakuljinda, W., Janvilisri, T., 2016: Multidrug resistance in Clostridium perfringens isolated from diarrheal neonatal piglets in Thailand. Anaerobe, 38, 88—89. DOI: 10.1016/j.anaerobe.2015.12.012.10.1016/j.anaerobe.2015.12.01226752714
- 31. Norman, K. N., Scott, H. M., Harvey, R. B., Norby, B. O., Hume, M. E., Andrews, K., 2011: Prevalence and genotypic characteristics of Clostridium difficile in a closed and integrated human and swine population. Appl. Environ. Microbiol., 77, 16, 5755—5760. DOI: 10. 1128/AEM. 05007-11.10.1128/AEM.05007-11316527121724899
- 32. Oren, A., Garity, G. M., 2016: List of new names and new combinations previously effectively, but not validly, published. IJSEM, 66, 12, 3761—3764. DOI: 10.1099/ijsem.0.001620.10.1099/ijsem.0.00162028079499
- 33. Paredes-Sabja, D., Sarker, M. R., 2012: Interactions between Clostridium perfringens spores and Raw 264.7 macrophages. Anaerobe, 18, 1, 148—156. DOI: 10.1016/j.anaerobe. 2011.12.019.
- 34. Parmley, J., Leung, Z., Léger, D., Finley, R., Irwin, R., Pintar, K., et al., 2012: One health and food safety, the Canadian experience: a holistic approach toward enteric bacterial pathogens and antimicrobial resistance surveillance. In Institute of Medicine (US):Improving Food Safety Through a One Health Approach: Workshop Summary. National Academics Press (US), Washington (DC), Accessed on September 18, 2018. https://www.ncbi.nlm.nih.gov/books/NBK114511/.
- 35. Aruda, P. H. E., 2014:Clostridium difficile Infection in Neonatal Piglets, Pathogenesis, Risk Factors and Prevention. Graduate thesis and dissertation paper, 2. http://lib.dr.iastate.edu/etd. Accessed in May, 2018.
- 36. R. I. M., 1992:Nigerian Livestock Resources, National Synthesis. Resource Inventory and Management Ltd., Jardine House, St. Helier, Jersey, UK, 2 pp.
- 37. Salvarani, F. M., Silveira-silver, R. O., Pires, P. S., da Costa Cruz Junior, E. C., Albefaro, I. S., de Carvalho Guedes, R. M, et al., 2012: Antimicrobial susceptibility of Clostridium perfringens isolated from piglets with or without diarrhoea in Brazil. Braz. J. Microbiol., 43, 3, 1030—1033. DOI: 10. 1590/S1517-838220120003000027.10.1590/S1517-83822012000300027
- 38. Silva, R. O. S., Junior, C. A. O., Guedes, R. M. C., Lobato, F. C. F., 2015:Clostridium perfringens: a review of the disease in pigs, horses and broiler chickens. Cienc. Rural, 4, 6, 1027—1034. DOI:10.1590/0103-8478cr20140927.10.1590/0103-8478cr20140927
- 39. Silva, S. O. R., Rupnik, M., Diniz, N. A., Vilela, G. E., Lobato, F. C. F., 2015:Clostridium difficile ribotypes in humans and animals in Brazil. Mem. Inst. Oswaldo Cruz, 110, 8, 1062—1065. DOI: 10.1590/0074-02760150294.10.1590/0074-02760150294470802826676318
- 40. Slavić, D., Boerlin, P., Fabri, M, Klotins, K. C., Zoethout, J. K., Weir, P. E., et al., 2011: Antimicrobial susceptibility of Clostridium perfringens isolates of bovine, chicken, porcine, and turkey origin from Ontario. Can. J. Vet. Res., 75, 2, 89—97.
- 41. Songer, J. G., 1996: Clostridial enteric diseases of domestic animals. Clin. Microbiol. Rev., 9, 2, 216—234. DOI:10.1128/CMR.9.2.216.10.1128/CMR.9.2.2161728918964036
- 42. Songer, J. G., Uzal, F. A., 2005: Clostridial enteric infections in pigs. J. Vet. Diagn. Invest., 17, 6, 528—536. DOI: 10.1177/104063870501700602.10.1177/10406387050170060216475510
- 43. Tansuphasiri, U., Matra, W., Sangsuk, L., 2005: Antimicrobial resistance among Clostridium perfringens isolated from various sources in Thailand. Southeast Asian J. Trop. Med. Public Health, 36, 4, 954—961.
- 44. Thrusfield, M., 1997:Veterinary Epidemiology. 2nd edn., Blackwell Scientific Publication, Oxford, 180—181.
- 45. Tizhe, J. Q., Bello, M., Kabir, J., Musa, J. A., Lamurde, N. J., 2015: Isolation and biochemical identification of Clostridium perfringens from raw beef sold in retail outlets in Zaria metropolis, Nigeria. IJCMAS, 4, 11, 23—39.
- 46. Uzal, F. A., Songer, J. G., 2008: Diagnosis of Clostridium perfringens intestinal infections in sheep and goats. J. Vet. Diagn. Invest., 20, 3, 253—265. DOI: 10.1177/104063870802000301.10.1177/10406387080200030118460610
- 47. van Asten, J. A. M., Nikolaou, G. N., Grone, A., 2010: The occurrence of cpb2-toxigenic Clostridium perfringens and the possible role of the b2-toxin in enteric disease of domestic animals, wild animals and humans. Vet. J., 183, 2, 135—140. DOI: 10.1016/j.tvjl.2008.11.005.10.1016/j.tvjl.2008.11.00519101180
- 48. van den Bogaard, A. E. J. M., London, N., Stobberingh, E. E., 2000: Antimicrobial resistance in pig faecal samples from The Netherlands (five abattoirs) and Sweden. J. Antimicrob. Chemother., 45, 5, 663—671. DOI: 10.1093/jac/45.5.663.10.1093/jac/45.5.66310797090
- 49. Weese, J. S., Wakeford, T., Reid-Smith, R., Rousseau, J., Friendship, R., 2010: Longitudinal investigation of Clostridium difficile shedding in piglets. Anaerobe, 16, 5, 501—504. DOI: 10.1016/j.anaerobe.2010.08.001.10.1016/j.anaerobe.2010.08.00120708700
- 50. Wilcox, M. H., 2012: Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection. Clin. Microbiol. Infect., 18, 6, 13—20. DOI: 10.1111/1469-0691. 12057.